Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of exercise in obesity-related cancers: Current evidence and biological mechanisms. (2023/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coincidence of plasma cell leukemia and COVID-19: a diagnostic pitfall. (2023/06/01) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, in silico and in vitro study. (2023/05/09) ♡
- Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma. (2023/05/01) ♡
- Integrative medicine in multiple myeloma and plasma cell disorders. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders. (2023/05/01) ♡
- Feasibility of Linking Area Deprivation Index Data to the OMOP Common Data Model. (2023/04/29) ♡
- Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis. (2023/04/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders. (2023/04/26) ♡
- Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype. (2023/04/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Smouldering Myeloma: Chasing a Hyperviscous Sample. (2023/04/01) ♡
- Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis. (2023/04/01) ♡
- Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma. (2023/04/01) ♡
- Efficacy of a Viokace Pancreatic Enzyme Protocol for Clearing Occluded Enteral Feeding Tubes: A Quality Assurance Evaluation. (2023/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series. (2023/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Isatuximab in multiple myeloma. (2023/04/01) ♡
- [Analysis of Long-Term Prognostic Factors Based on Nutritional Status in Patients with Multiple Myeloma]. (2023/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. NITROSOGENESIS OF SKIN (HUMAN) CANCER- THE HIDDEN TRUTH OF A NEVERENDING STORY: NITROSAMINE CONTAMINATION IN OLMESARTAN, VALSARTAN AND HCT AS MAIN RISK FACTOR FOR THE DEVELOPMENT OF KERATINOCYTE CANCER. (2023/04/01) ♡
- Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. (2023/03/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bibliometric Analysis of Acupuncture Therapy for Cancer Pain Over the Past 10 Years. (2023/03/20) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer. (2023/03/14) ♡
- Vitamin D and Multiple Myeloma: A Scoping Review. (2023/03/11) ♡
- Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients. (2023/03/01) ♡
- A Comprehensive Multidisciplinary Diagnostic Algorithm for the Early and Efficient Detection of Amyloidosis. (2023/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Obesity and myeloma: Clinical and mechanistic contributions to disease progression. (2023/02/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Distinguishing Curable from Progressive Dementias for Defining Cancer Care Options. (2023/02/07) ♡
- A Retrospective Analysis of Sternal Lesions Detected on Breast MRI in Patients Without History of Cancer. (2023/02/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas. (2023/02/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case Series of Aggressive Orbital Plasmacytomas. (2023/02/01) ♡
- The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma. (2023/02/01) ♡
- Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions. (2023/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Safety, Feasibility, and Efficacy of Exercise Interventions for People With Multiple Myeloma: A Systematic Review. (2023/02/01) ♡
- Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis. (2023/01/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Standardized classification schemes in reporting oncologic PET/CT. (2023/01/26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy. (2023/01/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Experts' consensus on the definition and management of high risk multiple myeloma. (2023/01/23) ♡
- Plerixafor and granulocyte colony stimulating factor for poor mobilizers in patients undergoing autologous peripheral hematopoietic stem cell transplantation: Single institution study. (2023/01/18) ♡
- Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma. (2023/01/17) ♡
- Dual targeting with (224)Ra/(212)Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach. (2023/01/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells. (2023/01/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrative Hematology: State of the Art. (2023/01/15) ♡
- Machine learning-based infection prediction model for newly diagnosed multiple myeloma patients. (2023/01/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Use of peripheral nerve stimulation for treatment of pain from vertebral plana fracture. (2023/01/12) ♡
- Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells. (2023/01/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the application of Raman spectroscopy in haematological tumours. (2023/01/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review. (2023/01/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma? (2023/01/05) ♡
- Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma. (2023/01/05) ♡
- Effects of physical activity on clinical and inflammatory markers in diagnosing multiple myeloma patients. (2023/01/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.